Showing results (401-410 of 1,609) with videos related to

Sort By:
Pageof 161
JAMA Oncology|July 15, 2021
Nivolumab Plus Ipilimumab vs Nivolumab for Previously Treated Patients With Stage IV Squamous Cell Lung Cancer: The Lung-MAP S1400I Phase 3 Randomized Clinical TrialScott N Gettinger, Mary W Redman, Lyudmila Bazhenova, et al.
JAMA Oncology|May 28, 2021
Difference in SARS-CoV-2 Antibody Status Between Patients With Cancer and Health Care Workers During the COVID-19 Pandemic in JapanShu Yazaki, Tatsuya Yoshida, Yuki Kojima, et al.
JAMA Oncology|May 28, 2021
Evaluation of Seropositivity Following BNT162b2 Messenger RNA Vaccination for SARS-CoV-2 in Patients Undergoing Treatment for CancerAmir Massarweh, Noa Eliakim-Raz, Amos Stemmer, et al.
JAMA Oncology|May 27, 2021
Comparison of the Prevalence of Pathogenic Variants in Cancer Susceptibility Genes in Black Women and Non-Hispanic White Women With Breast Cancer in the United StatesSusan M Domchek, Song Yao, Fei Chen, et al.
JAMA Oncology|June 16, 2022
Association of High Tumor Mutation Burden in Non-Small Cell Lung Cancers With Increased Immune Infiltration and Improved Clinical Outcomes of PD-L1 Blockade Across PD-L1 Expression LevelsBiagio Ricciuti, Xinan Wang, Joao V Alessi, et al.
JAMA Oncology|June 16, 2022
Enzalutamide Monotherapy vs Active Surveillance in Patients With Low-risk or Intermediate-risk Localized Prostate Cancer: The ENACT Randomized Clinical TrialNeal D Shore, Joseph Renzulli, Neil E Fleshner, et al.
JAMA Oncology|June 16, 2022
Efficacy and Safety of a Pegasparaginase-Based Chemotherapy Regimen vs an L-asparaginase-Based Chemotherapy Regimen for Newly Diagnosed Advanced Extranodal Natural Killer/T-Cell Lymphoma: A Randomized Clinical TrialXinhua Wang, Lei Zhang, Xiangli Liu, et al.
JAMA Oncology|December 15, 2022
Emerging Strategies for the Treatment of Small Cell Lung Cancer: A ReviewW Jeffrey Petty, Luis Paz-Ares
JAMA Oncology|December 15, 2022
Atezolizumab Plus Bevacizumab as First-line Treatment for Patients With Metastatic Nonsquamous Non-Small Cell Lung Cancer With High Tumor Mutation Burden: A Nonrandomized Controlled TrialMariano Provencio, Ana Laura Ortega, Juan Coves-Sarto, et al.
JAMA Oncology|December 29, 2022
Testing for EGFR Variants in Pleural and Pericardial Effusion Cell-Free DNA in Patients With Non-Small Cell Lung CancerKirsty W C Lee, Molly S C Li, Wanxia Gai, et al.
Pageof 161